Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bersalin Mustika Ayu is a traditional Indonesian herbal medicine (jamu) developed by Air Mancur (a subsidiary of Combiphar) for postpartum recovery. Formulated as pills and powders for a 40-day regimen, it is designed to support postpartum uterine recovery, restore stamina, cleanse lochia (postpartum discharge), tighten abdominal muscles, and promote lactation (breast milk production). The herbal formulation contains natural ingredients such as *Gallae* (oak galls), *Ocimi sancti Folium* (holy basil), *Retrofracti Fructus* (Javanese long pepper), *Imperatae Radix* (cogon grass), *Boesenbergiae Rhizoma* (fingerroot), *Curcumae Rhizoma* (temulawak), *Curcumae domesticae Rhizoma* (turmeric), and *Languatis Rhizoma* (galangal).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bersalin Mustika Ayu.